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Aims The aim of the current study was to evaluate the relationship between the presence of left ventricular (LV) dyssyn-




Sixty eight patients consecutive (LV ejection fraction 23+ 8%) with at least moderate MR (grade 2þ) were
included. Echocardiography was performed at baseline, 1 day after CRT initiation and at 6 months follow-up.
Speckle tracking radial strain was used to assess LV dyssynchrony at baseline. The majority of patients improved
in MR after CRT, with 43% improving immediately after CRT, and 20% improving late (after 6 months) after CRT.
Early and late responders had similar extent of LV dyssynchrony (209+115 ms vs. 190+118 ms, P ¼ NS);
however, the site of latest activation in early responders was mostly inferior or posterior (adjacent to the posterior
papillary muscle), whereas the lateral wall was the latest activated segment in late responders.
Conclusion Current data suggest that the presence of baseline LV dyssynchrony is related to improvement in MR after CRT. LV
dyssynchrony involving the posterior papillary muscle may lead to an immediate reduction in MR, whereas LV dys-
synchrony in the lateral wall resulted in late response to CRT.
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Introduction
Mitral regurgitation (MR) is a common finding in patients with
dilated cardiomyopathy and depressed left ventricular (LV) func-
tion. Progressive remodelling and dilation of the LV may lead to
annular enlargement and papillary muscle displacement resulting
in functional MR.
Since the number of these patients is increasing rapidly and the
presence of MR is associated with reduced survival,1–3 treatment
of MR is an important issue. Recent studies have demonstrated
that cardiac resynchronization therapy (CRT) may result in
improvement in MR.4–6 However, the mechanism of this improve-
ment in MR following CRT is not yet fully understood. LV dyssyn-
chrony involving the posterior mitral leaflet appeared to be a
determinant for the presence of MR.7 In addition, preliminary
data suggested that CRT can acutely reduce MR in patients with
dyssynchrony between the papillary muscles.8 Besides the acute
effect, reduction in MR has also been shown at long-term
follow-up after CRT, and is most likely secondary to LV reverse
remodelling.9,10
In this context, we assumed that patients with late activation
(dyssynchrony) of the myocardial segments adjacent to posterior
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papillary muscle will respond acutely in MR after CRT initiation,
whereas patients with late activation (dyssynchrony) of the
lateral LV segments will show late improvement in MR due to
LV reverse remodelling. Lastly, patients without dyssynchrony will
show neither an acute or chronic improvement in MR nor reverse
remodelling. To evaluate the role of dyssynchrony in reduction of
MR, we evaluated 68 consecutive patients with at least moderate
MR who underwent CRT. Transthoracic echocardiography was
used to assess indices of MR, and off-line analysis with speckle track-
ing radial strain was used to assess LV dyssynchrony.
Methods
Patients
Between January 2005 and September 2006, 68 patients with at least
moderate MR (grade 2þ) were selected from 206 patients eligible
for CRT in Leiden University Medical Center. Eligibility for CRT was
based on the current guidelines; moderate to severe heart failure
[New York Heart Association (NYHA) class III or IV], depressed LV
function (LV ejection fraction ,35%) and wide QRS complex
(120 ms).11 Twenty-five patients were included in a previous
paper.8 Patients with a recent myocardial infarction (,3 months), pre-
vious mitral valve surgery, or decompensated heart failure were
excluded. Etiology was considered ischaemic in the presence of signifi-
cant coronary artery disease (50% stenosis in one or more of the
major epicardial coronary arteries) and/or a history of myocardial infarc-
tion with electrocardiogram evidence, prior percutaneous coronary
intervention or prior coronary artery bypass graft.
Study protocol
Clinical status was assessed at baseline and after 6 months follow-up,
including assessment of NYHA class, quality of life (using the Minne-
sota Living with Heart Failure questionnaire),12 and evaluation of exer-
cise capacity using the 6 min hall walk test.13
Echocardiography was performed at baseline, the day after implan-
tation and at 6-months follow-up.
Echocardiographical evaluation
All patients underwent standard transthoracic 2D echocardiography,
including quantification of MR, LV function, global and local LV remo-
delling, and mitral valve deformation. All measurements were per-
formed the day before implantation (PRE), the day after implantation
(POST), and after 6 months of CRT (6 MO). Measurements of dyssyn-
chrony were only performed at baseline. Patients were imaged in the
left lateral decubitus position using a commercially available system
(Vingmed Vivid Seven, General Electric-Vingmed, Milwaukee, Wiscon-
sin, USA). Images were obtained using a 3.5 MHz transducer, at a
depth of 16 cm in the parasternal and apical views (standard long-axis
and 6-chamber images). Standard 2D and colour Doppler data, trig-
gered to the QRS complex, were saved in cine-loop format. For
each measurement, 3 cardiac cycles were averaged. All echocardio-
graphic measurements were obtained by two independent observers.
The severity of MR was graded semi-quantitatively from colour-flow
Doppler images using the apical four-chamber views. Left atrial (LA)
and regurgitant jet area were measured by planimetry, allowing calcu-
lation of the ratio of the jet area to the LA area.14,15 In addition, vena
contracta width was measured.16 The severity of MR was graded on a
four-point scale: mild ¼ 1þ ( jet area/LA area ,10%), moderate ¼ 2þ
( jet area/LA area 10–20%, vena contracta ,0.3 cm), 3þ ¼ moder-
ately severe ( jet area/LA area 20–45%, vena contracta 0.3–0.7 cm),
4þ ¼ severe ( jet area/LA area .45%, vena contracta .0.7 cm).17
Inter- and intraobserver agreement for jet area/LA area showed a
mean value of differences respectively of 1.6% (95% limits of agree-
ment from 27.2–10.3%) and 0.1% (95% limits of agreement 22.9–
3.1%) and for vena contracta 20.03 cm (95% limits of agreement
from 20.21 to 0.16 cm) and 0.01 cm (95% limits of agreement from
20.07 to 0.10 cm). The maximal rate of LV systolic pressure increase
(LV dP/dt) was estimated from the steepest rising segment on the con-
tinuous wave Doppler regurgitant jet.18
Mitral deformation indices included valvular tenting area, coaptation
height and mitral annular contraction. The valvular tenting area was
obtained from the parasternal long-axis view at mid-systole and was
measured as the area enclosed between the annular plane and mitral
leaflets. Displacement of mitral coaptation (coaptation height)
towards the LV apex was measured by the distance between leaflet
coaptation and the mitral annulus plane in the apical four-chamber
view. Mitral annulus diameter was measured at end-systole and end-
diastole in the four-chamber view. Annular contraction was calculated
as (end-diastolic diameter—end-systolic diameter) / end-diastolic
diameter.19
LV volumes [end-diastolic volume (LVEDV), end-systolic volume
(LVESV)] and LV ejection fraction were calculated from the conven-
tional apical two- and four-chamber images, using the biplane
Simpson’s technique.20 The apical displacement of posterior papillary
muscle was proposed to represent the global LV remodelling and
was measured as the distance between the posterior papillary
muscle head and the intervalvular fibrosa (PPM-fibrosa) in the long-
axis view.19 For assessment of LA remodelling several parameters
were calculated. The antero-posterior diameter was measured at end-
systole on the M-mode image obtained from the parasternal long-axis
view.21 Short- and long-axis of the LA were measured on apical four-
chamber views at end-systole. Furthermore, LA volumes were
measured on apical two- and four-chamber views using the biplane
Simpson’s rule.22,23 LA end-systolic volume (LAESV) was defined as
the largest LA volume in ventricular systole; LA end-diastolic volume
(LAEDV) was defined as the smallest possible LA volume in ventricular
diastole.
LV dyssynchrony was calculated using speckle tracking radial strain
analysis applied to baseline LV short-axis images at the papillary
muscle level.24,25 Time–strain curves for all the six segments (septal,
anteroseptal, anterior, posterior, lateral, and inferior) were con-
structed. Peak radial strain and time from QRS onset to peak radial
strain were obtained. Consequently, the location of the earliest and
latest activated segments and the heterogeneity in time-to-peak
radial strain for the six segments were determined.26 LV dyssynchrony
was defined as the maximal time difference between the earliest and
latest activated segments; the site of latest activation was also noted
(Figure 1). Inter- and intraobserver agreement for LV dyssynchrony
showed a mean value of differences of respectively 211.5 ms (95%
limits of agreement 273.5 to 50.4 ms) and 7.4 ms (95% limits of agree-
ment from 210.7 to 25.5 ms).
Definition of response in mitral regurgitation
after cardiac resynchronization therapy
At 6-month follow-up, the patients were divided into three groups
based on the improvement in MR. ‘Early responders’ were defined
as patients who improved at least one grade in MR immediately after
implantation. Patients who showed an improvement of at least one
grade MR after 6 months of CRT were classified as ‘late responders’.
‘Non-responders’ showed no improvement or even deterioration in
MR during follow-up.
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Cardiac resynchronization therapy
implantation
A coronary sinus venogram was obtained using balloon catheter, fol-
lowed by the insertion of the LV pacing lead. An 8F guiding catheter
was used to position the LV lead (Easytrak 4512–80, Guidant Corpor-
ation, St Paul, MN, USA; or Attain-SD 4189, Medtronic Inc., Minneapolis,
MN, USA) in the coronary sinus. The preferred position was a lateral
or postero-lateral vein.27 The right atrial and ventricular leads
were positioned conventionally. All leads were connected to a dual
chamber biventricular implantable cardioverter-defibrillator (Contak
Renewal II or H195, Guidant Corporation; or Insync III or Insync
Sentry, Medtronic Inc.).
Statistical analysis
Continuous variables are expressed as mean+ SD. Categorical data
are summarized as frequencies and percentages. Inter- and intraobser-
ver agreements for severity of MR and LV dyssynchrony parameters
are calculated using Bland–Altman analysis in a subset of 20 patients.
The 95% limits of agreement were defined as the range of values+
2SDs from the mean value of differences. Patients were randomly
selected and time between measurements by the same reader was
.1 week. Differences in baseline characteristics between early-, late-
and non-responders were analysed using one-way analysis of variance
(ANOVA) with post hoc Bonferroni testing (continuous variables) and
x2 or Fisher’s exact tests (dichotomous variables) as appropriate. The
relation between response-pattern and change in echocardiographic
parameters over time was then studied using repeated measures
two-way ANOVA. We assumed that every pair of measurements
has the same correlation coefficient across subjects and that the var-
iance and covariances are homogenous across time. This specific
structure for the covariance is referred to as compound symmetry,
and it is reasonable to assume such structure in view of the relatively
short follow-up (6 months). The paired Students t test was used to
compare continuous data within the three subgroups during follow-up.
In acute responders and non-responders mitral deformation indices
and parameters indicating LV function measured immediately after
implant were compared with the baseline values, whereas in late
responders and non-responders the 6 months follow-up measure-
ments were compared with baseline. LA function and volumes
measured at baseline and at 6 months follow-up were compared
within all the three groups. To adjust for inflation of the type I error
with multiple tests, we applied a Bonferroni correction; for changes
in mitral deformation indices and LV function we considered a
P-value of ,0.05/4 statistically significant; for changes in LA function
and volumes, a P-value of ,0.05/3 was considered significant.
Results
Patient characteristics
Baseline characteristics of the 68 consecutive patients (48 men, age
68+9 years) included in this study are summarized in Table 1. All
patients had central jets, secondary to LV dilatation; 24 patients
(35%) having moderate MR (grade 2þ), 36 patients (53%) having
moderately severe MR (grade 3þ) and eight patients (12%) had
severe MR (4þ) before CRT implantation. Most patients had
NYHA class III (93%) and mean LV ejection fraction was 23+
8%. All patients received optimized medical therapy, if tolerated.
Device implantation was successful in all patients and no
Figure 1 Time–strain curves from the mid-ventricular short-
axis view for the six standard segments [yellow: antero-septal;
red: anterior; green: lateral; purple: posterior; dark blue: inferior;
and light blue: septal left ventricular (LV) segment]. LV dyssyn-
chrony is present in this example as indicated by the difference
in timing of peak strain between the earliest and latest activated
segment of 255 ms. The latest activated segment is the lateral
LV segment
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Table 1 Baseline characteristics of the study
population
All patients (n5 68)
Age (years) 68+9
Gender (M/F) 48/20
NYHA class (III/IV) 63/5
Ischaemic etiology 39 (57%)
QRS duration (ms) 159+31
LBBB configuration 52 (76%)
SR/AF/paced 55/8/5
Grade MR (2þ/3þ/4þ) 24/36/8
LV ejection fraction (%) 23+8
LVEDV (mL) 251+80
LVESV (mL) 197+75







ACE, angiotensin-converting enzyme; AF, atrial fibrillation; LBBB, left bundle
branch block; LV, left ventricular; LVEDV, left ventricular end-diastolic volume;
LVESV, left ventricular end-systolic volume; MR, mitral regurgitation; NYHA,
New York Heart Association; SR, sinus rhythm.
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procedure-related complications were observed. However, seven
patients died of worsening heart failure before the 6-month
follow-up evaluation.
Clinical and functional improvement after
cardiac resynchronization therapy
After 6 months of CRT, 40 patients improved one NYHA class and
five patients improved two NYHA classes (McNemar test, P,
0.001). The quality-of-life score decreased from 35+18 to
22+19 (P, 0.001). In addition, a significant increase in 6 min
walking distance was noted (from 290+ 110 m to 374+127 m,
P, 0.001).
One day after implantation, LVESV showed a modest decrease
from 197+95 mL to 190+ 76 mL (P, 0.001) accompanied
with an improvement in LV ejection fraction (from 23+8% to
25+9%, P, 0.001). Significant reverse remodelling was observed
at 6 months follow-up, as evidenced by a decrease in LVEDV from
251+ 80 mL at baseline to 216+ 89 mL (P, 0.001) after 6
months of CRT. Similarly, LVESV decreased from 197+ 75 mL
to 155+80 mL (P, 0.001). Furthermore, the LV ejection fraction
improved from 23+8% to 30+ 10% (P, 0.001).
Improvement in mitral regurgitation
after cardiac resynchronization therapy
Immediately after CRT 26 patients improved one grade in MR and
three patients improved two grades, resulting in 29 early respon-
ders (43%). The group of late responders comprised 14 patients
(20%); 12 patients showed a reduction of one grade in MR, two
patients showed a reduction of two grades after 6 months.
Twenty-five patients (37%) were considered non-responders,
including the patients who died before 6 months of follow-up.
Early responders showed an immediate reduction in severity of
MR after CRT, which was maintained or even further, reduced
after 6 months of CRT (Figure 2, Table 2). In contrast, late respon-
ders exhibited reduction in MR only after 6 months of CRT. In the
non-responder group, severity of MR did not change during the
entire follow-up.
Regarding mitral deformation indices, Figure 3 demonstrates sig-
nificant differences in trend during follow-up between acute, late
and non-responders. Acute improvement in MR was accompanied
by an acute significant improvement in tenting area (from 7.8+
1.0 cm2 to 7.2+0.9 cm2, P, 0.001), coaptation height (from
1.9+ 0.2 cm to 1.8+0.2 cm, P, 0.001) and mitral annular con-
traction (from 16+4% to 20+4%, P, 0.001). This improvement
was even more pronounced after 6 months of CRT. In the late
responders these mitral deformation indices did not improve
acutely after CRT, but did improve after 6 months (in all P,
0.005). Lastly, the non-responder group showed neither improve-
ment in MR as well as in tenting area, coaptation height, and mitral
annular contraction during the entire follow-up.
Furthermore, Figure 3 also demonstrates acute local remodelling
after initiation of CRT in acute responders, as demonstrated by an
acute reduction in PPM-fibrosa distance from 6.7+ 0.5 cm to
6.4+ 0.6 cm (P, 0.001), with a further reduction to 6.1+
0.6 cm after 6 months. Local LV remodelling in late responders
was noted only after 6 months (from 6.7+ 0.7 cm to 6.2+
0.7 cm, P, 0.001). The non-responders showed no change at all
in local LV remodelling. Global changes in LV function were also
noted in acute responders as demonstrated by an immediate
improvement in LV dP/dt, a reduction in LVESV, and conse-
quently an improvement in LV ejection fraction (all parameters
P, 0.001, Table 2). This improvement was maintained or even
further improved after 6 months of CRT, with significant LV
reverse remodelling. Late responders showed a reduction in LV
volumes and improvement in LV function after 6 months of
follow-up (P, 0.001). Non-responders in MR showed no
improvement in indices of global LV remodelling during the
entire follow-up. Of note, 72% of the early responders and 93%
Figure 2 Colour Doppler images of an ‘acute responder’.
Acute reduction in mitral regurgitation is seen immediate after
cardiac resynchronization therapy (B) compared with baseline
(A). (C) Demonstrates a sustained reduction at 6-months
follow-up
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of the late responders showed .15% reduction in LVESV after
6 months as compared with only four patients (20%) in the non-
responder group (P, 0.001).
LA remodelling was only assessed at 6 months follow-up (Table
3). LA diameters showed a significant reduction during follow-up in
early responders (P, 0.001) with a trend for reduction in late
responders (P ¼ 0.034 for LA LAX and P ¼ 0.040 for LA SAX).
LA volumes, however, were significantly decreased. Non-
responders showed no LA reverse remodelling.
Left ventricular dyssynchrony and
improvement in mitral regurgitation
As demonstrated in Table 4, baseline characteristics of all three
patient groups were similar except for the indices of LV dyssyn-
chrony at baseline. Of note, speckle tracking analysis was possible
in all but three patients due to technically inadequate short-axis
images and 18 segments (5%) of the remaining 390 segments
had to be eliminated because of negative strain values.
Non-responders showed less LV dyssynchrony at baseline com-
pared with early and late responders (99+ 74 ms vs. 209+
115 ms vs. 190+118 ms, P, 0.001). Early and late responders
had similar extent of LV dyssynchrony; however, the site of
latest activation in early responders was the posterior or the
inferior LV segment, which is adjacent to the posterior papillary
muscle, whereas in late responders the site of latest activation
was the lateral LV segment (Figure 4).
In contrast, evaluation of 100 random CRT candidates without
(34%) or mild MR (grade 1þ, 66%) demonstrated similar extent
of LV dyssynchrony as compared with patients with at least mod-
erate MR (167+122 ms vs. 163+120 ms, P ¼ 0.8). However,
different distribution of site of latest activation was noted (Figure
5), with the lateral segment contracting latest in the majority of
patients. Interestingly, only 18% of the patients demonstrated
late contraction of the posterior and inferior segments.
Discussion
The results of the current study can be summarized as follows: (i)
the majority of patients included in this study improved in MR after
CRT, with 43% improving immediately after CRT, and 20%
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Table 2 Effect of cardiac resynchronization therapy on severity of mitral regurgitation (MR) and left ventricular (LV)
function and LV volumes between patients who show an acute improvement in MR (Early), a late improvement after 6
months of follow-up (Late) or no improvement at all (Non). The following comparisons were made: in early responders
PRE vs. POST; in late responders PRE vs. 6 MO and in non-responders both. The corresponding P-values are added
between brackets. To correct for repeated measurements a P-value of <0.013 was considered statistically significant
Early (n5 29) Late (n 5 14) Non (n5 25) P-value
MR (grade) PRE 2.8+0.6 2.8+0.7 2.8+0.7 1.0
POST 1.7+0.7 (P, 0.001) 2.8+0.7 2.8+0.7 (P ¼ 0.7)
6 MO 1.6+0.8 1.7+0.7 (P, 0.001) 2.9+0.8 (P ¼ 0.4)
Jet area (cm2) PRE 7.1+3.2 7.9+4.0 7.0+4.7 0.7
POST 3.5+1.9 (P, 0.001) 7.9+4.0 7.8+4.2 (P ¼ 0.8)
6 MO 3.0+1.3 3.7+2.1 (P, 0.001) 8.5+4.9 (P ¼ 0.3)
Jet area/LA area (%) PRE 34+13 34+15 35+15 1.0
POST 18+9 (P, 0.001) 34+15 34+14 (P ¼ 0.3)
6 MO 17+8 20+11 (P, 0.001) 35+15 (P ¼ 0.7)
Vena contracta (cm) PRE 0.46+0.16 0.46+0.22 0.42+0.20 0.8
POST 0.31+0.12 (P, 0.001) 0.47+0.20 0.43+0.19 (P ¼ 0.7)
6 MO 0.31+0.10 0.27+0.14 (P, 0.001) 0.44+0.18 [P¼0.3]
LV dP/dt (mmHg/s) PRE 669+335 705+444 702+239 1.0
POST 1134+608 (P, 0.001) 851+451 714+185 (P ¼ 0.6)
6 MO 1123+605 1174+496 (P ¼ 0.005) 721+265 (P ¼ 0.8)
LVESV (mL) PRE 194+81 191+48 205+82 0.8
POST 182+82 (P, 0.001) 187+48 201+81 (P ¼ 0.1)
6 MO 142+83 134+50 (P, 0.001) 189+87 (P ¼ 0.3)
LVEDV (mL) PRE 251+82 241+46 256+94 0.8
POST 249+83 (P ¼ 0.4) 243+44 259+92 (P ¼ 0.2)
6 MO 204+91 195+54 (P, 0.001) 249+102 (P ¼ 0.9)
LV ejection fraction (%) PRE 24+8 22+7 22+8 0.5
POST 28+9 (P, 0.001) 24+9 23+8 (P ¼ 0.1)
6 MO 33+10 33+9 (P, 0.001) 25+8 (P ¼ 0.1)
LA, left atrial; LV, left ventricular; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume.
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improving late (at 6 months) after CRT; (ii) the site of latest
activation (the most dyssynchronous region) in early responders
was mostly posterior or inferior (close to the posterior papillary
muscle), whereas the lateral wall was the latest activated
segment in late responders; (iii) improvement in MR was
accompanied by an improvement in mitral deformation indices,
as well as in global and local LV reverse remodelling as in LA
remodelling.
Mechanism of mitral regurgitation
in dilated cardiomyopathy
The development of functional MR in dilated cardiomyopathy has
been attributed to annular enlargement secondary to the LV dila-
tation and papillary muscle displacement due to LV remodelling,
which results in tethering and mitral valve tenting.28,29 Boltwood
et al.30 have reported that annular dilatation is the main
Figure 3 Effects of cardiac resynchronization therapy on mitral deformation indices (A–C) and global left ventricular remodelling (D) immedi-
ately after implantation (POST) and after 6 months (6 MO). Patients are grouped into early, late and non-responders according to the improve-
ment in their mitral regurgitation. The P-value indicates a significant difference in trend during follow-up between the three groups. (Asterisk:
PRE vs. POST P, 0.001; dagger: PRE vs. 6 MO P, 0.001; double dagger PRE vs. 6 MO P, 0.005)
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Table 3 Effect of cardiac resynchronization therapy (CRT) on left atrial size and volumes between patients who show an
acute improvement in mitral regurgitation (MR) (Early), a late improvement after 6 months of follow-up (Late) or no
improvement at all (Non)
Early (n 5 29) Late (n5 14) Non (n5 25) P-value
LA diameter (cm) PRE 4.7+0.7 4.8+0.8 4.9+0.8 0.7
6 MO 4.3+0.8a 4.5+0.8a 4.8+0.9
LA LAX (cm) PRE 5.2+0.4 5.3+0.7 5.3+1.1 0.8
6 MO 4.8+0.6a 5.0+0.6 5.2+0.9
LA SAX (cm) PRE 4.5+0.6 4.4+0.7 4.2+0.9 0.9
6 MO 3.9+0.8a 4.0+0.8 4.2+0.9
LAESV (mL) PRE 63+21 70+23 66+29 0.6
6 MO 53+22a 60+23a 69+31
LAEDV (mL) PRE 49+17 50+20 48+28 1.0
6 MO 41+17a 40+21a 48+34
LA, left atrium; LAESV, left atrial end-systolic volume; LAEDV, left atrial end-diastolic volume; LAX, long-axis; SAX, short-axis.
aPRE vs. 6 MO P, 0.001.
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determinant of MR in patients with dilated cardiomyopathy. Other
studies have demonstrated that systolic mitral valve tenting is the
main determinant of mitral valve incompetence.28,29,31 Lancellotti
et al.19 demonstrated in 70 ischaemic patients that severity of
MR at rest best correlated with changes in mitral deformation
(tenting area, coaptation height) during exercise. Moreover, pos-
terior displacement of the papillary muscle was associated with
severity of MR.
The presence of LV dyssynchrony may also contribute to MR.
LV dyssynchrony decreases LV contraction efficiency and closing
forces thereby impairing mitral valve tenting.4 Moreover, dyssyn-
chrony between the LV segments supporting the papillary
muscles produces uncoordinated regional LV mechanical activation
in these segments, resulting in geometric changes in mitral leaflet
attachments and implying tethering of the mitral leaflets.5 For
instance, in previous work we measured a time delay of 169+
69 ms between maximal contraction of the anterior papillary
muscle and the posterior papillary muscle in 25 patients with
moderate-severe MR.8
Acute vs. late improvement in mitral
regurgitation
CRT has been reported to reduce MR. However, some patients
exhibit immediate reduction in MR, whereas other patients show
improvement only late after CRT. Indeed, several acute CRT
studies reported an acute MR reduction.4–6 For instance, Lancel-
lotti and coworkers studied 27 patients (LV ejection fraction
29+5%) with CRT on and off, and demonstrated that MR
improved immediately after CRT, with a reduction in effective
regurgitant orifice area from 22+10 mm2 to 13+7 mm.2,6 Fur-
thermore, these changes in MR were directly related to changes
in LV systolic function (LV dP/dt). The likely cause of the improve-
ment in MR was concluded to be a decrease in LVESV and coordi-
nation of ventricular contraction, leading to restoration of mitral
valve closure. Kanzaki et al.5 noted a similar reduction in MR sever-
ity and added the role of papillary muscle resynchronization during
CRT. Along with the reduction in MR severity, the inter-papillary
muscle time delay shortened from 106+74 ms at baseline to
39+43 ms after CRT (P, 0.001). Furthermore, the change in
inter-papillary muscle time delay correlated well with the decrease
in MR severity after CRT (r ¼ 0.77, P, 0.001). Similar results from
our group concerning the mechanism of acute reduction in MR
after CRT were reported recently.8 At baseline, a time delay of
169+69 ms between the anterior and the posterior papillary
muscle was present, that decreased immediately to 25+46 ms
after CRT along with a reduction in MR severity (evidenced by a
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Table 4 Baseline characteristics in patients who show
an acute improvement in mitral regurgitation after
cardiac resynchronization therapy (Early), a late
improvement after 6 months of follow-up (Late) or no






(n 5 25) P-value
Age (years) 68+10 71+7 66+8 0.3
Gender (M/F) 19/10 10/4 19/6 0.7
NYHA class (III/IV) 28/1 13/1 22/3 0.5
Ischaemic etiology 19 (56%) 6 (43%) 14 (56%) 0.4
QRS duration (ms) 157+29 175+33 153+31 0.1
LBBB
configuration
22 (76%) 10 (71%) 20 (80%) 0.3
SR/AF/Paced 25/1/3 10/2/2 20/5/0 0.4
Grade MR (2þ/
3þ/4þ)
9/18/2 5/7/2 11/12/4 0.7
LV ejection
fraction (%)
24+8 22+7 22+8 0.5
LVEDV (mL) 251+82 241+46 256+94 0.8
LVESV (mL) 194+81 191+48 205+82 0.8
LV dyssynchrony
(ms)
209+115 190+118 99+74 ,0.001
AF, atrial fibrillation; LBBB, left bundle branch block; LV, left ventricular; LVEDV,
left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume;
MR, mitral regurgitation; NYHA, New York Heart Association; SR, sinus rhythm.
Figure 5 Distribution of site of latest activation in 100 cardiac
resynchronization therapy patients without significant mitral
regurgitation (MR) at baseline (AS: antero-septal; ANT: anterior;
LAT: lateral, POST: posterior, INF: inferior, SEPT: septal LV
segment)
Figure 4 Distribution of site of latest activation between early
and late responders in improvement in mitral regurgitation after
cardiac resynchronization therapy (AS: antero-septal; ANT:
anterior; LAT: lateral, POST: posterior, INF: inferior, SEPT:
septal LV segment)
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reduction in vena contracta width from 0.54+15 cm to 0.39+
0.13 cm, P, 0.001).
Besides the acute effect of CRT on MR, reduction in MR has also
been shown at long-term follow-up; data from the MIRACLE trial
and other large trials have demonstrated a significant reduction in
average MR jet area and MR severity after CRT.9,10 Thus, immedi-
ate reduction in MR severity can be attributed to resynchronized
papillary muscle activation and improved coordination of LV con-
traction, which results in improved systolic function and reduced
mitral leaflet tethering forces. The likely cause of late improvement
in MR is LV reverse remodelling leading to a reduction in mitral
annular size, with restoration of mitral valve closure. Of note,
late responders in MR also show an acute improvement in
LVESV probably as a result of a decrease in LV dyssynchrony
with a coordinated contraction.
The current study evaluated the different mechanisms of
reduction in MR after CRT. Importantly, the majority of patients
(63%) demonstrated a reduction in MR severity after CRT,
either acute or late. Acute improvement in MR severity was
accompanied by acute improvements in mitral deformation, LV
function and LA function, which were maintained or improved
even further during late follow-up. Late improvement in MR
(after 6 months of CRT), was accompanied by LV reverse remo-
delling, global LV remodelling and improved mitral deformation
indices. Interestingly, both acute and late responders exhibited
severe baseline LV dyssynchrony, but a different location of LV dys-
synchrony was noted in both groups. In acute responders the
inferior or posterior segments showed the latest activation,
whereas in late responders the lateral wall showed the latest acti-
vation. The posterior papillary muscles are located adjacent to the
inferior or posterior LV segments, suggesting involvement of the
papillary muscle in the dyssynchrony in acute responders. This
hypothesis is further supported by the fact that patients without
significant MR have similar extent of LV dyssynchrony but show
less often a posterior or inferior site of latest activation. Future
larger studies are warranted to further elucidate the role of dyssyn-
chrony in functional MR.
Conclusions
The observations in the present study indicate that the improve-
ment in MR after CRT is related to the presence of LV dyssyn-
chrony. If the LV dyssynchrony involves the posterior papillary
muscle an immediate reduction in MR can be expected after
CRT (secondary to resynchronization of the posterior papillary
muscle), whereas in patients with LV dyssynchrony not involving
the posterior papillary muscle late improvement in MR can be
expected (related to LV reverse remodelling with subsequent
reduction in mitral annular size and improved closure of the valve).
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